Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Fortune Oil & Gas, Inc.
MILFORD, Pa., June 17, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (OTCPink: FOGC), today announced that its wholly owned subsidiary, Manzo Pharmaceuticals has released its first retail product to be available to the public. It is a remedy for babies with excess gas, which often causes a condition known as colic. The product, called Manzo's Tummy Relief, is currently available for purchase on Amazon.com.
Colic is defined as periods of continuous crying for more than three hours per day, and although many other ailments can cause the condition, stomach and intestinal gas is often the culprit. Manzo's solution is a natural, safe and effective liquid given to the infant in the form of drops. Compared to competitors, Manzo's solution contains larger amounts of the effective ingredients, costs less, does not contain many unnatural or even harmful additives that other remedies do, and it comes in a unique spill proof bottle that avoids those frustrating spills and allows for more efficient use of the product with less waste. With competitor's products, it is difficult to get all of the liquid out of the bottle because of the design of the packaging causing waste, and costing consumers more money, but with Manzo's design, consumers can use every last drop in the bottle saving time and money.
The company's CEO, Kenneth Manzo developed the product and designed the packaging with more than his expertise in pharmaceuticals in mind. As a parent himself he knows how inefficient and expensive these types of remedies can be. "I wanted to offer parents a solution that actually worked well and didn't break the bank. New parents have a lot of things to stress about, especially when their baby has colic. If we can give peace of mind to even one household at an affordable price, it was worth it. I think parents will be clamoring for bottles of Tummy Relief because frankly, there is nothing available to consumers that is as good," explained Mr. Manzo. You can find out all about Tummy Relief on the product website at www.tummy-relief.com.
Manzo also wanted to let shareholders know that the company has a lot of exciting developments lined up. Most immediate is that the company is preparing to file for a name change and hopes to have that done within the next week or two. This is a critical step in the overall strategy because once completed, the company will be ready to really begin utilizing the media to get its message out there, so it is shaping up to be a very exciting summer for Manzo Pharmaceuticals.
About Fortune Oil & Gas, Inc.
Fortune Oil & Gas, Inc. owns and operates Manzo Pharmaceuticals, a specialty pharmaceutical company engaged in the research, development, and testing of patented and non-patented solutions and remedies. Most notably is a patented solution for lactose Intolerance, and a natural remedy for colic in babies. For more information follow the company on twitter at @manzopharma, and visit www.manzopharma.com.
DISCLAIMER: ?This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.
©2012 PR Newswire. All Rights Reserved.